21 Partners sells Almaviva Santé

November 11, 2013

21 Partners is pleased to announce the sale of Almaviva Santé, the leading network of private clinics in the Marseille region, to a consortium of private equity investors gathering GIMV and UI Gestion.

Founded in 2007 by 21 Partners and CEO entrepreneur Bruno Marie, Almaviva Santé is composed of seven clinics, all top-rated in the south of France. The successful consolidation strategy, adding clinics in increments, allowed to build a platform of medical excellence with renowned specialties and leading practices in the fields of orthopedic and ophthalmic surgery.

The achievement of market consolidation combined with an expansion of the healthcare service range, remaining at the forefront of medical advances allowed to attract top level medical practitioners, thus further reinforcing the strategic value of the group.

21 Partners has also supported Almaviva Santé in the structuring of its platform to improve efficiency through the development of a group quality standard policy. This ensured that Almaviva Santé was consistently granted the highest certifications and attracted a growing number of patients. Moreover, the implementation of purchasing and medical synergies led to significant value creation through operational performance improvements.

With a staff of over 600 practitioners and 1,000 employees, a capacity of nearly 800 beds and 65 surgical units Almaviva Santé totals over 100 000 stays units, 100,000 and 70,000 surgeries per year. The group generates in excess of €M 100 in revenues.

Gérard Pluvinet, Founding Managing Partner and Henry Huyghues Despointes, Partner at 21 Partners commented: “Almaviva Santé, created in 2007 through the acquisition of the Chantecler clinic and built up over the past few years is a prime example of 21’s know-how in driving market consolidation and creating leaders.

Bruno Marie CEO of Almaviva Santé added: “We carefully built this platform putting the medical staff Marie, Santé, staff, our most important asset, at the heart of the integration of new clinics. We are very pleased by the course of the partnership with 21 which gave the group the means to grow and to become a reference in the market.”

ProductLife Group expands to India and Central Europe

After having acquired French-based AxPharma and US-based DS InPharmatics, PLG continues its dynamic development with this new build-up. It allows the group, acquired by 21 Invest France in 2019, to establish itself in India and strengthen its position in Central Europe, thus enhancing its value proposition with offshoring capacities.
Read more
Load More
Fail to load posts. Try to refresh page.